Presented Positive Interim Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Presented Positive Interim Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Presented Positive Interim Data Today - Breaking & Trending Today

Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights

Published: February 29, 2024

- Announced positive topline data from the ongoing Phase 1A/B clinical trial of SL-172154 in combination with azacitidine (AZA) in frontline Highe...

Source: businessinsider.com

Related Topics:

United StatesNorth CarolinaConor RichardsonMirvetuximab SoravtansineTaylor SchreiberAmerican Society Of HematologyExchange CommissionShattuck Labs IncCancer ResearchOno Pharmaceutical Co LtdHealth Care Conference BostonDevelopment Rd ExpensesRna Work In Cancer ResearchHigher Risk Myelodysplastic SyndromesAcute Myeloid LeukemiaAmerican SocietyAnnual MeetingChief Executive OfficerCancer CellMilestones ExpectedStage PipelineInitial EnrollmentOngoing PhaseClinical TrialPresented Positive Interim Data

Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights

Published: February 29, 2024

- Announced positive topline data from the ongoing Phase 1A/B clinical trial of SL-172154 in combination with azacitidine in frontline Higher-Risk Myelodysplastic Syndromes and frontline TP53 mutant...

Source: marketscreener.com

Related Topics:

United StatesNorth CarolinaTaylor SchreiberConor RichardsonMirvetuximab SoravtansineCancer ResearchRna Work In Cancer ResearchShattuck Labs IncOno Pharmaceutical Co LtdExchange CommissionDevelopment Rd ExpensesHealth Care Conference BostonAmerican Society Of HematologyHigher Risk Myelodysplastic SyndromesAcute Myeloid LeukemiaAmerican SocietyAnnual MeetingChief Executive OfficerCancer CellMilestones ExpectedStage PipelineInitial EnrollmentOngoing PhaseClinical TrialPresented Positive Interim Data